ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100. A total of 118 filers reported holding ALLAKOS INC in Q3 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15 | -46.4% | 6,465 | 0.0% | 0.00% | – |
| Q2 2023 | $28 | -99.9% | 6,465 | +11.6% | 0.00% | – |
| Q1 2022 | $33,000 | -95.0% | 5,793 | -6.8% | 0.00% | -100.0% |
| Q3 2021 | $658,000 | +16.9% | 6,218 | -5.8% | 0.01% | +20.0% |
| Q2 2021 | $563,000 | +31.5% | 6,599 | +76.9% | 0.01% | -68.8% |
| Q1 2021 | $428,000 | -25.2% | 3,730 | -8.7% | 0.02% | -27.3% |
| Q4 2020 | $572,000 | +85.7% | 4,085 | +7.9% | 0.02% | +69.2% |
| Q3 2020 | $308,000 | +10.0% | 3,787 | -2.7% | 0.01% | 0.0% |
| Q2 2020 | $280,000 | -24.7% | 3,894 | -0.3% | 0.01% | +85.7% |
| Q4 2019 | $372,000 | +54.4% | 3,904 | +27.1% | 0.01% | +40.0% |
| Q3 2019 | $241,000 | – | 3,071 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 270,965 | $12,055,000 | 6.94% |
| NEA Management Company, LLC | 2,268,188 | $100,912,000 | 5.27% |
| Fairmount Funds Management LLC | 178,662 | $7,949,000 | 4.82% |
| Redmile Group, LLC | 2,976,928 | $132,444,000 | 3.71% |
| Boxer Capital, LLC | 675,000 | $30,031,000 | 2.05% |
| Rock Springs Capital Management LP | 235,000 | $10,455,000 | 0.43% |
| Cormorant Asset Management, LP | 200,000 | $8,898,000 | 0.41% |
| RAMIUS ADVISORS LLC | 31,155 | $1,386,000 | 0.35% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 15,700 | $692,000 | 0.32% |
| Handelsinvest Investeringsforvaltning | 20,000 | $890,000 | 0.24% |